Emerging role of long acting muscarinic antagonists for asthma
Author:
Affiliation:
1. Asthma and Allergy Research Group; Medical Research Institute; Ninewells Hospital and Medical School; University of Dundee; Scotland UK
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12123/fullpdf
Reference51 articles.
1. Global strategy for asthma management and prevention: GINA executive summary;Bateman;Eur Respir J,2008
2. Anticholinergic agents for chronic asthma in adults;Westby;Cochrane Database Syst Rev,2004
3. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Vestbo;Am J Respir Crit Care Med,2013
4. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study;Bateman;Am J Respir Crit Care Med,2004
5. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?;Lipworth;Trends Pharmacol Sci,2007
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-08-21
2. Burden and unmet needs in asthma care in the Asia‐Pacific region;Public Health Challenges;2022-08-29
3. Combination Therapy for COPD: Efficacy and Prospects of Multiple Therapy;Highlights in Science, Engineering and Technology;2022-08-17
4. Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies;Journal of Asthma;2022-05-30
5. Synergy across the drugs approved for the treatment of asthma;Minerva Medica;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3